Early occurence of hepatocellular carcinoma in patients with and without cirrhosis after HCV treatment with direct-acting antivirals

被引：0
|
作者：
Finkelmeier, F. [1 ]
Dultz, G. [2 ]
Kronenberger, B. [3 ]
Peiffer, K-H. [4 ]
Krauss, F. [2 ]
Zeuzem, S. [4 ]
Sarrazin, C. [5 ]
Vermehren, J. [6 ]
Waidmann, O. [4 ]
机构：
[1] Univ Klin Frankfurt Ukf, Gastroenterol, Frankfurt, Germany
[2] Uniklin Frankfurt, Frankfurt, Germany
[3] Herz Jesu Krankenhaus, Fulda, Germany
[4] Uniklin Frankfurt, Med Klin 1, Frankfurt, Germany
[5] Med Klin II, Gastroenterol, Wiesbaden, Germany
[6] Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
389
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [31] PIVKA II a useful biomarker for hepatocellular carcinoma in caucasian HCV cirrhotic patients treated with direct-acting antivirals
    Degasperi, E.
    De Monti, A.
    Perbellini, R.
    D'Ambrosio, R.
    Lunghi, G.
    Ceriotti, F.
    Perego, A.
    Orsini, C.
    Borghi, M.
    Iavarone, M.
    Bruccoleri, M.
    Sangiovanni, A.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E10 - E11
  • [32] Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
    D'Ambrosio, Roberta
    Degasperi, Elisabetta
    Lampertico, Pietro
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 713 - 739
  • [33] Direct-acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic?
    Pol, Stanislas
    Vallet-Pichard, Anais
    Fontaine, Helene
    Carrat, Fabrice
    LIVER INTERNATIONAL, 2019, 39 (03) : 446 - 447
  • [34] Things fall apart with hepatocellular carcinoma and direct-acting antivirals
    Kutala, Blaise
    Valla, Dominique
    Marcellin, Patrick
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 107 - 109
  • [35] HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HCV RELATED CIRRHOSIS TREATED WITH DIRECT ACTING ANTIVIRALS: A SMOKING GUN OR GUILT BY ASSOCIATION?
    Ali, Bilal
    Imam, Mohamad
    Groeschell, Chip
    Patel, Kruti
    Gadiparthi, Chiranjeevi
    Gonzalez, Humberto C. Gonzalez
    Nair, Satheesh
    Satapathy, Sanjaya K.
    GASTROENTEROLOGY, 2017, 152 (05) : S1095 - S1096
  • [36] Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals: comparative analysis with non-direct-acting antivirals-treated patients
    Abdelaziz, Ashraf O.
    Nabil, Mohamed M.
    Abdelmaksoud, Ahmed H.
    Shousha, Hend I.
    Hashem, Mohamed B.
    Hassan, Eman M.
    Salah, Ayman
    Omran, Dalia A.
    Elbaz, Tamer M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 75 - 79
  • [37] Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
    Chi, Chen-Ta
    Chen, Chi-Yi
    Su, Chien-Wei
    Chen, Po-Yueh
    Chu, Chi-Jen
    Lan, Keng-Hsin
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (03) : 385 - 395
  • [38] REDUCTION OF SPLENIC VOLUME AFTER DIRECT ACTING ANTIVIRALS TREATMENT IN PATIENTS WITH HCV COMPENSATED CIRRHOSIS
    Mihai, F.
    Cucuteanu, B.
    Lupascu-Ursulescu, Corina
    Negru, D.
    Sfarti, C.
    Cuciureanu, T.
    Cojocaru, Camelia
    Singeap, Ana-Maria
    Stanciu, C.
    Trifan, Anca
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2020, 124 (02): : 225 - 230
  • [39] Direct-acting antiviral treatment for patients with hepatocellular carcinoma
    Kushner, Tatyana
    Dieterich, Douglas
    Saberi, Behnam
    CURRENT OPINION IN GASTROENTEROLOGY, 2018, 34 (03) : 132 - 139
  • [40] INCIDENCE OF HEPATOCELLULAR CARCINOMA AND EXTRAHEPATIC CANCERS AMONG HCV-INFECTED PATIENTS IN THE ERA OF DIRECT-ACTING ANTIVIRALS
    Wang, W.
    Lo Re, I. I. I., V
    Xiao, H.
    Brown, J.
    Yi, G.
    Park, H.
    VALUE IN HEALTH, 2018, 21 : S12 - S13
12345